Allurion Technologies Inc. (NYSE:ALUR) Short Interest Update

Allurion Technologies Inc. (NYSE:ALUR) was the recipient of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 125,700 shares, a drop of 34.0% from the February 13th total of 190,500 shares. Approximately 2.5% of the shares of the stock are sold short. Based on an average daily volume of 1,400,000 shares, the days-to-cover ratio is currently 0.1 days.

Allurion Technologies Price Performance

Shares of NYSE:ALUR traded down $0.04 during midday trading on Friday, hitting $2.40. The company had a trading volume of 34,477 shares, compared to its average volume of 393,161. The business’s 50-day simple moving average is $4.44 and its 200-day simple moving average is $10.65. The stock has a market cap of $11.51 million, a price-to-earnings ratio of -0.20 and a beta of -0.59. Allurion Technologies has a twelve month low of $2.15 and a twelve month high of $98.75.

Institutional Investors Weigh In On Allurion Technologies

An institutional investor recently raised its position in Allurion Technologies stock. Geode Capital Management LLC boosted its holdings in shares of Allurion Technologies Inc. (NYSE:ALUR) by 40.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 516,330 shares of the company’s stock after acquiring an additional 149,484 shares during the quarter. Geode Capital Management LLC owned about 0.80% of Allurion Technologies worth $317,000 at the end of the most recent quarter. Institutional investors own 21.39% of the company’s stock.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.